Advertisement

Topics

Cambridge Investment Research Ltd Company Profile

15:10 EDT 24th September 2018 | BioPortfolio

CIR is here to help companies solve their problems and reach their goals. We like new ideas, modern ways of thinking. We won't work with companies unless we think we can help. We only take on projects where our goals are in line with those we work with. CIR set up and runs the high value, technology manufacturing event series (HVM Series). This is a powerful set of newstyle events with talks, expos, and marketplaces for technology companies, product makers and assemblers, and brand owners.

Location

United Kingdom

Contact

Phone: 44 1223 303500


News Articles [1284 Associated News Articles listed on BioPortfolio]

Bristol-Myers Squibb Co (BMY) Shares Bought by Cambridge Investment Research Advisors Inc.

Cambridge Investment Research Advisors Inc. boosted its position in shares of Bristol-Myers Squibb Co by 4.7% in the first quarter, according to its most recent filing with the Securities and Exchange...

#jobs #lifescience Senior Product Manager – Biotech – Cambridge

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Senior Product Manager – Biotech – Cambridge .MA-Cambridge, We ar...

Ahren Fund to Invest $10 Million in Cambridge Epigenetix

Eight so-called “superstar scientists” based in Cambridge, UK, have co-founded an investment fund dubbed Ahren with 100 million pounds, so far. One of their first investments is in biotech company...

PlaqueTec sets up new science base at Babraham Research campus in Cambridge

The company has also expanded its headquarters and device development facilities, which are now located in Cambourne Business Park, also in Cambridge. PlaqueTec is leading biomarker-based cardiovascul...

Professor Greg Hannon to Become Director of the Cancer Research UK Cambridge Institute

Cancer Research UK and the University of Cambridge are pleased to announce the appointment of Professor Greg Hannon as the new director of the Cancer Research UK Cambridge Institute, today (Thursday).

Cambridge Analytica Suspends CEO After Alarming Reports On Its Election Maneuvers

Cambridge Analytica, the British political research group linked to President

Cambridge Research Biochemicals supports evaluation of new Fuchs Dystrophy treatment

Cambridge Research Biochemicals has announced that under the terms of a new contract with Leidos Biomedical Research, it will support the evaluation of a new treatment approach for Fuchs Dystrophy

AI & Machine Learning in Clinical Trials, APRIL 12, 2018 PFIZER INNOVATION RESEARCH LAB – CAMBRIDGE, MA

AI & Machine Learning in Clinical Trials, APRIL 12, 2018 PFIZER INNOVATION RESEARCH LAB – CAMBRIDGE, MA   Aviva Lev-Ari, PhD, RN, Director and Founder of  LPBI Group,   will atte...

PubMed Articles [1082 Associated PubMed Articles listed on BioPortfolio]

The Cambridge Social History of Modern Ireland : Edited by E.F. Biagini and M.E. Daly, Cambridge, United Kingdom and New York, NY: Cambridge University Press, 2017.

Are microbiome studies ready for hypothesis-driven research?

Hypothesis-driven research has led to many scientific advances, but hypotheses cannot be tested in isolation: rather, they require a framework of aggregated scientific knowledge to allow questions to ...

Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.

The aim of this study was to perform a return-on-investment (ROI) analysis of a breast cancer screening program in Egypt by comparing net profit in treatment costs saved to program cost investment.

Did carbon dioxide emission regulations inhibit investments? A provincial panel analysis of China.

Investments, especially fixed asset investments, greatly affect carbon dioxide (CO) emissions. When investments are concentrated in regions with high CO emissions and high fossil energy consumption, t...

Maternal condition and maternal investment during lactation in mantled howler monkeys.

Lactation is a costly reproductive state for females, as it may entail decreased body condition, increased morbidity, and increased mortality risk. To offset these costs, mothers should allocate inves...

Clinical Trials [1154 Associated Clinical Trials listed on BioPortfolio]

Weight Loss for Obese Individuals With Gout

This study evaluates effect of weight loss in a group of obese patients with gouty arthritis. The study is a randomised group trial where half the patients receive intensive weight loss in...

Determine Return on Investment in Heart Failure Remote Monitoring Program

The study will test a hypothesis that the remote monitoring with text and email alerts sent to study subject and optional family/other caregiver (Intervention 1) will have a higher return ...

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

A three site study to evaluate the reproducibility of the Aina HbA1c Monitoring System in quantitative determination of glycosylated hemoglobin (HbA1c) took place at the following sites: ...

Color Vision as a Measure for Inherited Retinal Diseases

Background: - The purpose of this study is to find out whether color vision measured with the Cambridge Color Test is a good way to examine the severity of inherited retinal diseases (IRD...

Mother-Child Relationships During Pregnancy Among Bofi Foragers

This study will examine changes in mother-child relationships when mothers are pregnant, because this period may involve conflicts between mothers and children. A widely held evolutionary...

Companies [2427 Associated Companies listed on BioPortfolio]

Cambridge Cognition Ltd

Cambridge Cognition Ltd specialises in computerised cognitive testing. Based in Cambridge, England, the company supplies products and services based on CANTAB®, the Cambridge Neuropsychological Test ...

Cambridge Biomedical, Inc.

Cambridge Biomedical is a contract research organization (CRO) and diagnostic laboratory providing bioanalytical support to the pharmaceutical, biotechnology, and medical d...

Funxional Therapeutics Limited

Funxional Therapeutics is a privately held, clinical stage pharmaceutical company based in Cambridge (UK) which focuses on novel anti-inflammatory therapies. FXT is managed by a very experienced t...

Edison Investment Research

Edison Investment Research is Europe’s leading investment research company. The team of more than 70 includes over 40 analysts supported by a department of supervisory analys...

Funxional Therapeutics

Funxional Therapeutics is a privately held, clinical stage pharmaceutical company based in Cambridge (UK). The Company focuses on the discovery and development of novel anti-infla...

More Information about "Cambridge Investment Research Ltd" on BioPortfolio

We have published hundreds of Cambridge Investment Research Ltd news stories on BioPortfolio along with dozens of Cambridge Investment Research Ltd Clinical Trials and PubMed Articles about Cambridge Investment Research Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cambridge Investment Research Ltd Companies in our database. You can also find out about relevant Cambridge Investment Research Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record